Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dalteparin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02159287
What this trial is testing

Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke

Who this might be right for
Embolic Stroke
Shiraz University of Medical Sciences 80
Not applicableUnknownNCT05066867
What this trial is testing

LMWH Compliance in Pregnancy

Who this might be right for
Venous ThromboembolismAntenatal Deep Vein Thrombosis
Cork University Maternity Hospital 100
Not applicableStudy completedNCT00773006
What this trial is testing

Canadian Anticoagulant Percutaneous Coronary Intervention Registry

Who this might be right for
Coronary Artery Disease
University of Alberta 747
Not applicableStudy completedNCT01133002
What this trial is testing

Canadian Outpatient VTE Management Registry

Who this might be right for
Medical Prevention Therapy
Sanofi 915
Post-approval studies (Phase 4)Study completedNCT02161965
What this trial is testing

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

Who this might be right for
Permanent Atrial FibrillationVenous ThrombosisPulmonary Embolism+1 more
University Hospital, Angers 51
Large-scale testing (Phase 3)Study completedNCT00362947
What this trial is testing

Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis

Who this might be right for
Thrombophlebitis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 664
Post-approval studies (Phase 4)Study completedNCT01245998
What this trial is testing

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis

Who this might be right for
Superficial Thrombophlebitis
University Medical Centre Ljubljana 68
Not applicableStudy completedNCT04444804
What this trial is testing

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

Who this might be right for
Venous Thromboembolism
Bayer 22,153
Testing effectiveness (Phase 2)UnknownNCT00293501
What this trial is testing

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
University of Vermont 35
Post-approval studies (Phase 4)Study completedNCT01390051
What this trial is testing

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?

Who this might be right for
Fetal Growth Retardation
University of Aarhus 50
Not applicableUnknownNCT01626911
What this trial is testing

Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis

Who this might be right for
Acute Pancreatitis
Nanjing University School of Medicine 60
Not applicableStudy completedNCT02744092
What this trial is testing

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

Who this might be right for
CancerVenous ThromboembolismDeep Vein Thrombosis (DVT)+2 more
Alliance Foundation Trials, LLC. 811
Large-scale testing (Phase 3)Study completedNCT00451412
What this trial is testing

A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients

Who this might be right for
Thromboembolism
Novartis 3,254
Post-approval studies (Phase 4)UnknownNCT00450645
What this trial is testing

Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis

Who this might be right for
Deep Vein ThrombosisCancer
Azienda Ospedaliera Universitaria Policlinico 300
Large-scale testing (Phase 3)UnknownNCT01019655
What this trial is testing

Heparin for Pregnant Women With Thrombophilia

Who this might be right for
Pregnancy and Thrombophilia
Medical University of Vienna 300
Large-scale testing (Phase 3)Study completedNCT00421538
What this trial is testing

Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)

Who this might be right for
Distal (Calf) Deep-vein Thrombosis
University Hospital, Geneva 260
Testing effectiveness (Phase 2)Study completedNCT03282643
What this trial is testing

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

Who this might be right for
Neoplasms
Capital Medical University 74
Post-approval studies (Phase 4)UnknownNCT02658838
What this trial is testing

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

Who this might be right for
LOVASTATIN/TICAGRELOR [VA Drug Interaction]
Beijing Anzhen Hospital 300
Large-scale testing (Phase 3)Study completedNCT02774265
What this trial is testing

A Different Approach to Preventing Thrombosis

Who this might be right for
Venous ThromboembolismPulmonary Embolism
University of Maryland, Baltimore 329
Large-scale testing (Phase 3)UnknownNCT00370760
What this trial is testing

Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)

Who this might be right for
Proliferative Vitreoretinopathy
Shahid Beheshti University of Medical Sciences
Next Page